Strategies for addressing adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines

Journal of Psychiatric Practice

Volumn 16, Issue 5, 2010, Pages 306-324

  Velligan, Dawn I ^a   Weiden, Peter J ^b   Sajatovic, Martha ^c   Scott, Jan ^d   Carpenter, Daniel ^e   Ross, Ruth ^g   Docherty, John P ^f  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e Comprehensive NeuroScience Inc ^*  (United Kingdom)

^f Department of Obstetrics Gynecology   (United States)

^g NONE

Author keywords

adherence; bipolar disorder; expert consensus guidelines; interventions; medication; schizophrenia

Indexed keywords

FLUPHENAZINE DECANOATE; HALOPERIDOL DECANOATE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; RISPERIDONE; VALPROIC ACID;

ATTITUDE TO HEALTH; BIPOLAR DISORDER; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FAMILY THERAPY; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SOCIAL SUPPORT;

BIPOLAR DISORDER; CHRONIC DISEASE; COGNITION; CONSENSUS; HUMANS; MENTAL DISORDERS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SOCIAL ENVIRONMENT; SOCIAL SUPPORT;

EID: 77957556520     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000388626.98662.a0     Document Type: Review

References (68)

1. Velligan DI, Lam F, Ereshefsky L, et al. Psychopharma-cology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 2003;54: 665-7.
2. Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(suppl 4). (Available at www.psychia-trist.com/private/supplenet/v70s04, accessed August 18, 2010).
3. Velligan DI, Weiden PJ, Sajatovic M, et al. Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the Expert Consensus Guidelines. J Psychiatr Pract 2010;16:34-45.
4. Julius RJ, Novitsky MA, Dubin WR. Medication adherence: A review of the literature and implications for clinical practice. J Psychiatr Pract 2009;15:34-44.
5. Scott J. Cognitive and behavioural approaches to medication adherence. Advances in Psychiatric Treatment 1999; 5:338-47.
6. Scott J, Tacchi M. A pilot study of concordance therapy in individuals with bipolar disorders who are non-adherent with lithium prophylaxis. Bipolar Disord 2002;4:286-93.
7. Turkington D, Dudley R, Warman DM, et al. Cognitive-behavioral therapy for schizophrenia: A review. J Psychiatr Pract 2004;10:5-16.
8. Turkington D, Kingdon D, Weiden PJ. Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006;163: 365-73.
9. Cochran S. Preventing medication non-compliance in the outpatient treatment of bipolar affective disorder. J Consult Clin Psychol 1984;52:873-8.
10. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004;55:264-9.
11. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: Randomized controlled trial. BMJ 1996;312:345-9.
12. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998;172:413-9.
13. Maneesakorn S, Robson D, Gournay K, et al. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs 2007;16:1302-12.
14. Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry 2006;189:508-14.
15. Miklowitz DJ. A review of evidence-based psychosocial interventions for bipolar disorder. J Clin Psychiatry 2006;67(Suppl 11):28-33.
16. Frank E, Swartz HA, Boland E. Interpersonal and social rhythm therapy: An intervention addressing rhythm dys-regulation in bipolar disorder. Dialogues Clin Neurosci 2007;9:325-32.
17. Kisely S, Campbell LA, Preston N. Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev 2005 Jul 20;(3):CD004408.
18. Velligan DI, Diamond PM, Mintz J, et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull 2008;34:483-93.
19. Spaniel F, Vohlídka P, Hrdlicka J, et al. ITAREPS: Information technology aided relapse prevention programme in schizophrenia. Schizophr Res 2008;98:312-7.
20. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000;(2):CD001089.
21. Marshall M, Gray A, Lockwood A, et al. Case management for people with severe mental disorders. Cochrane Database Syst Rev 2000;(2):CD000050.
22. Lincoln TM, Wilhelm K, Nestoriuc Y. Effectiveness of psy-choeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis. Schizophr Res 2007;96:232-45.
23. Tacchi MJ, Scott J. Improving adherence in schizophrenia and bipolar disorders. Chichester, England: John Wiley & Sons; 2005.
24. Mohamed S, Rosenheck R, McEvoy J, et al.Cross-section-al and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull 2009;35: 336-46.
25. Uzenoff SR, Perkins DO, Hamer RM, et al. A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis. J Nerv Ment Dis 2008;196:572-5.
26. Vieta E. Improving treatment adherence in bipolar disor- der through psychoeducation. J Clin Psychiatry 2005; 66(suppl 1):24-9.
27. Rouget BW, Aubry JM. Efficacy of psychoeducational approaches on bipolar disorders: A review of the literature. J Affect Disord 2007;98:11-27.
28. Bowskill R, Clatworthy J, Parham R, et al. Patients' perceptions of information received about medication prescribed for bipolar disorder: Implications for informed choice. J Affect Disord 2007;100:253-7.
29. Dixon L, McFarlane WR, Lefley H, et al. Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatr Serv 2001;52:903-10.
30. Dolder CR, Lacro JP, Leckband S, et al. Interventions to improve antipsychotic medication adherence: Review of recent literature. J Clin Psychopharmacol 2003;23: 389-99.
31. Chan SW, Yip B, Tso S, et al. Evaluation of a psychoedu-cation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ Couns 2009;75: 67-76.
32. Pharoah F, Mari J, Rathbone J, et al. Family intervention for schizophrenia. Cochrane Database Syst Rev 2006 Oct 18;(4):CD000088.
33. Reinares M, Colom F, Sánchez-Moreno J, et al. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: A randomized controlled trial. Bipolar Disord 2008;10:511-9.
34. Miklowitz DJ, George EL, Richards JA, et al. A randomized study of family-focused psychoeducation and phar-macotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003;60:904-12.
35. Hudson TJ, Owen RR, Thrush CR, et al. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J Clin Psychiatry 2008;69:74-80.
36. Perkins DO, Gu H, Weiden PJ, et al. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: A randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry 2008;69:106-13.
37. Weiden PJ, Preskorn SH, Fahnestock PA, et al. Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: A roadmap. J Clin Psychiatry 2007;68(suppl 7):1-46.
38. Davis JM, Matalon L, Watanabe MD, et al. Depot antipsy-chotic drugs. Place in therapy. Drugs 1994;47:741-73.
39. Olivares JM, Rodriguez-Martinez A, Burón JA, et al. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia: A 12- and 24-month follow-up from the e-STAR database in Spain. Appl Health Econ Health Policy 2008;6:41-53.
40. Weiden PJ. New developments and research in treatment adherence in schizophrenia: An expert interview with Peter J. Weiden. Highlights of the American College of Neuropsychopharmacology (ACNP) 46th Annual Meeting. Medscape interview, posted January 31,2008. (Available at cme.medscape.com/viewarticle/ 569527, accessed August 18, 2010).
41. Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol 1998;8:55-66.
42. Weiden P, Rapkin B, Zygmunt A, et al. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen. Psychiatr Serv 1995;46: 1049-54.
43. Valenstein M, Copeland LA, Owen R, et al. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J Clin Psychiatry 2001;62: 545-51.
44. Patel MX, de Zoysa N, Bernadt M, et al. A cross-sectional study of patients' perspectives on adherence to antipsy-chotic medication: Depot versus oral. J Clin Psychiatry 2008;69:1548-56.
45. Bond DJ, Pratoomsri W, Yatham LN. Depot antipsychotic medications in bipolar disorder: A review of the literature. Acta Psychiatr Scand Suppl 2007(434);3-16.
46. Pfeiffer PN, Ganoczy D, Valenstein M. Dosing frequency and adherence to antipsychotic medications. Psychiatr Serv 2008;59:1207-10.
47. Scott J. Cognitive and behavioural approaches to medication adherence. Advances in Psychiatric Treatment 1999; 5:338-47.
48. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63:1121-8.
49. Masand PS, Narasimhan M. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol 2006;1:47-56.
50. Valencia M, Rascon ML, Juarez F, et al. A psychosocial skills training approach in Mexican out-patients with schizophrenia. Psychol Med 2007;37:1393-1402.
51. Reilly-Harrington N, Sachs GS. Psychosocial strategies to improve concordance and adherence in bipolar disorder. J Clin Psychiatry. 2006;67:e04.
52. Depp CA, Lebowitz BD, Patterson TL, et al. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: Development and pilot study. Bipolar Disord 2007;9:636-45.
53. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: State of the evidence. Am J Psychiatry 2008;165: 1408-19.
54. Duckworth K, Fitzpatrick MJ. NAMI perspective on CATIE: Policy and research implications. Psychiatr Serv 2008;59:537-9.
55. Rathod S, Kingdon D, Smith P, et al. Insight into schizophrenia: The effects of cognitive behavioural therapy on the components of insight and association with sociode-mographics - data on a previously published randomised controlled trial. Schizophr Res 2005;74:211-9.
56. Turkington D, Kingdon D, Turner T, et al. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002;180: 523-7.
57. McEvoy JP, Scheifler PL, Frances A. The expert consensus guideline series: Treatment of schizophrenia 1999. J Clin Psychiatry 1999;60(Suppl 11):1-80.
58. Keck PE, Perlis RH, Otto MW, et al. The expert consensus guideline series: Treatment of bipolar disorder 2004. Postgrad Med Special Report 2004; December:1-116.
59. Velligan DI, Mueller J, Wang M, et al. Use of environmental supports among patients with schizophrenia. Psychiatr Serv 2006;57:219-24.
60. Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv 2006;57:1636-9.
61. Mistler LA, Drake RE. Shared decision making in antipsychotic management. J Psychiatr Pract 2008;14: 333-4.
62. Davies MA, McBride L, Sajatovic M. The collaborative care practice model in the long-term care of individuals with bipolar disorder: A case study. J Psychiatr Ment Health Nurs 2008;15:649-53.
63. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(4 Suppl):1-50.
64. International consensus group on the evidence-based pharmacologic treatment of bipolar I and II depression. J Clin Psychiatry 2008;69:1632-46.
65. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: Treatment of residual depression and sedation. Bipolar Disord 2004;6: 416-20.
66. Kane JM, Leucht S, Carpenter D, et al. The expert consensus guideline series: Optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry 2003; 64(suppl 12):1-100.
67. Weiden PJ, Rao N. Teaching medication compliance to psychiatric residents: Placing an orphan topic into a training curriculum. Acad Psychiatry 2005;29:203-10.
68. Scott J, Tacchi MJ. Can we improve the detection and management of medication non-adherence in severe mental disorders? Results of a training programme for multi-disciplinary teams. Proceedings, 5th European Stanley Conference on Bipolar Disorder, Barcelona, Spain, October 5-7, 2006:2-46.